Swine Flu Vaccine Shortfall, or Why US Health Care Needs Greater Governmental Oversight
Barbara Ehrenreich explains that the shorfall of H1N1 vaccine in the United States is due to the failure of US pharmaceutical companies to meet their self-imposed production targets. This failure is the direct result of pharmaceuticals choosing to pursue profits rather than provide public service. In particular, pharmaceutical companies chose not to employ modern virus production methods (developed with government funding) in favor of a cheaper and slower 50-year old technology involving the production of the virus in chicken eggs, a method long since abandoned by China and the European Union.
Color me sickened.